Joanne M. Donovan Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Joanne M. Donovan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Joanne M. Donovan. Joanne M. Donovan is a Chief Medical Officer in CATABASIS PHARMACEUTICALS INC ($CATB) and a CMO; SVP Clinical Development in CATABASIS PHARMACEUTICALS INC ($CATB).

Address: C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE 02139 MA

Companies in which Joanne M. Donovan is an Insider

CATABASIS PHARMACEUTICALS INC

Trading Symbol: CATB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joanne M. Donovan: CMO; SVP Clinical Development, Chief Medical Officer
Holdings: 409 shares
Current Value: $503
Latest Transaction: Feb 14 2020
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Joanne M. Donovan

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 14 2020CATBCATABASIS PHARMACE ...Donovan Joanne M.CMO; SVP Clinical D ...Option ExerciseA5.3260,000319,20060,000
Feb 15 2019CATBCATABASIS PHARMACE ...Donovan Joanne M.CMO; SVP Clinical D ...Option ExerciseA4.3940,000175,60040,000
Sep 11 2018CATBCATABASIS PHARMACE ...Donovan Joanne M.CMO; SVP Clinical D ...Option ExerciseA0.71150,000106,500150,000
Feb 09 2018CATBCATABASIS PHARMACE ...Donovan Joanne M.CMO; SVP Clinical D ...Option ExerciseA1.28100,000128,000100,000
Sep 12 2016CATBCATABASIS PHARMACE ...Donovan Joanne M.CMO; SVP Clinical D ...Option ExerciseA4.3045,000193,50045,000
Feb 16 2016CATBCATABASIS PHARMACE ...Donovan Joanne M.Chief Medical Offic ...Option ExerciseA4.5766,000301,62066,000
Jun 30 2015CATBCATABASIS PHARMACE ...Donovan Joanne M.Chief Medical Offic ...Option ExerciseC0.005,26100

View all Joanne M. Donovan insider transactions.